Department of Pediatrics

Clinical Interests

Dr. Hollander’s clinical interests include all pediatric endocrine disorders and diabetes mellitus. She has a more focused interest in treatment of endocrine problems in children with brain tumors and has been a member of the multidisciplinary neuro-oncology team for St. Louis Children’s Hospital for over 15 years. She participates in clinical research regarding growth disorders in children with neurofibromatosis. Dr. Hollander is a co-leader of a multidisciplinary team providing care for children with disorders of sex development and adolescents with gender dysphoria.

Education

• BA, Cornell University, 1982
• MD, University of Cincinnati College of Medicine, 1986

Training

• Residency , Northwestern University Children's Memorial Hospital, 1986 - 1989
• Fellowship, Washington University School of Medicine, 1989 - 1992

Licensure and Board Certification

• 1986 - PresNational Board of Medical Examiners
• 1989 - 2006American Board of Pediatrics
• 1989 - 2014MO, Medical State License
• 1992 - PresPediatrics Endocrinology

Honors and Awards

• First-place abstract, National Cooperative Growth Study Investigators Meeting, 1995
• First-place abstract, National Cooperative Growth Study Investigators Meeting, 1998
• Distinguished Community Service Award, Washington University School of Medicine, 2009
• “America’s Top Pediatricians”, Consumers’ Research Council of America, 2009 - 2011
• “The Leading Physicians of the World”, International Association of Healthcare Professionals, 2009 - 2011
• “Best Doctors in St. Louis”, St. Louis Magazine, 2011 - Pres
• “Best Doctors in America”, Best Doctors, Inc, 2011 - 2012

Recent Publications view all (15)

Publication Co-Authors

David H. Gutmann, MD, PhD, FAAN

Marwan Shinawi, M.D.

Ina E. Amarillo, PhD FACMG ErCLG

Gary S Gottesman

Dennis J. Dietzen, Ph.D.

Joshua B. Rubin, M.D., Ph.D.

Allison King, M.D., M.P.H., Ph.D.

Jennifer Heeley

Bess A. Marshall, M.D.

Washington University has a long tradition of collaboration amongst colleagues.The faculty above have co-authored publications with Abby Hollander, M.D.

1. Hollander A. Commentary on a Curious Case of Primary Amenorrhea Clin Chem. 2020;66(9):1155. doi:10.1093  PMID:32870994 
2. Schoer MB, Nguyen P, Merritt D, Wesevich V, Hollander AS. Role of patient advocacy and the declining rate of clitoroplasty in 46,XX congenital adrenal hyperplasia Clinical Pediatrics. 2018;57(14):1664-1671. doi:10.1177/0009922818803407  PMID:30261740 
3. Zessis NR, Gao F, Vadlamudi G, Gutmann DH, Hollander AS. Height growth impairment in children with neurofibromatosis type 1 is characterized by decreased pubertal growth velocity in both sexes J Child Neurol. 2018. doi:10.1177/0883073818786807  
4. Heeley JM, Hollander AS, Austin PF, Merritt DF, Wesevich VG, Washington University School of Medicine in St. Louis DSD Team, Amarillo IE. Risk association of congenital anomalies in patients with ambiguous genitalia: a 22-year single-center experience J Pediatr Urol. 2018;14(2):153.e1-153.e7. doi:10.1016/j.jpurol.2017.09.027  PMID:29157626 
5. Otaify GA, Whyte MP, Gottesman GS, McAlister WH, Eric Gordon J, Hollander A, Andrews MV, El-Mofty SK, Chen WS, Veis DV, Stolina M, Woo AS, Katsonis P, Lichtarge O, Zhang F, Shinawi M. Gnathodiaphyseal dysplasia: Severe atypical presentation with novel heterozygous mutation of the anoctamin gene (ANO5). Bone. 2018;107:161-171. PMCID:PMC5987759  PMID:29175271 
6. Hughes J, Wyckoff J, Hollander A, Derdeyn C, McGill J. Moyamoya syndrome causing stroke in young women with type 1 diabetes Journal of diabetes and its complications. 2016;(8):1640-1642. doi:10.1016/j.jdiacomp.2016.08.004 PMID:27592256  
7. Amarillo IE, Nievara I, Hagan A, Huchthagowder V, Heeley J, Hollander A, Koenig J, Austin P, Wang T. Integrated small copy number variations and epigenomic maps of disorders of sex development Human genome Variation. 2016. doi:10.1038/hgv.2016.12  PMID:27340555 
8. Mailhot Vega R, Kim J, Hollander A, Hattangadi-Gluth J, Michalski J, Tarbell NJ, Yock TI, Bussiere M, MacDonald SM. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children. Cancer. 2015;121(10):1694-702. doi:10.1002/cncr.29209  PMID:25641407 
9. Mailhot Vega RB, Kim J, Bussière M, Hattangadi J, Hollander A, Michalski J, Tarbell NJ, Yock T, MacDonald SM. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma. Cancer. 2013;119(24):4299-307. doi:10.1002/cncr.28322  PMID:24105630 
10. Soucy EA, van Oppen D, Nejedly NL, Gao F, Gutmann DH, Hollander AS. Height assessments in children with neurofibromatosis type 1. J Child Neurol. 2013;28(3):303-7. doi:10.1177/0883073812446310  PMCID:PMC3947790  PMID:22752476 
11. Hollander AS. Commentary. Clin Chem. 2013;59(2):351. doi:10.1373/clinchem.2012.185678  PMID:23358749 
12. Mansur DB, Rubin JB, Kidd EA, King AA, Hollander AS, Smyth MD, Limbrick DD, Park TS, Leonard JR. Radiation therapy for pilocytic astrocytomas of childhood. Int J Radiat Oncol Biol Phys. 2011;79(3):829-34. doi:10.1016/j.ijrobp.2009.11.015  PMID:20421157 
13. Green RP, Hollander AS, Thevis M, Thomas A, Dietzen DJ. Detection of surreptitious administration of analog insulin to an 8-week-old infant. Pediatrics. 2010;125(5):e1236-40. doi:10.1542/peds.2009-2273  PMID:20385635 
14. Lin LL, El Naqa I, Leonard JR, Park TS, Hollander AS, Michalski JM, Mansur DB. Long-term outcome in children treated for craniopharyngioma with and without radiotherapy. J Neurosurg Pediatr. 2008;1(2):126-30. doi:10.3171/PED/2008/1/2/126  PMID:18352781 
15. Hollander AS, Olney RC, Blackett PR, Marshall BA. Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males. Pediatrics. 2003;111(6 Pt 1):1447-52. PMID:12777570